Search results
Showing 931 to 945 of 2042 results for guidelines
Biographies of the NICE executive team and minutes of their meetings
Tenofovir disoproxil for the treatment of chronic hepatitis B (TA173)
Evidence-based recommendations on tenofovir disoproxil for treating chronic hepatitis B.
Frequency of application of topical corticosteroids for atopic eczema (TA81)
Evidence-based recommendations on using topical corticosteroids for people with atopic eczema.
NICE has developed a medtech innovation briefing (MIB) on FreeStyle Libre for glucose monitoring .
Evidence-based recommendations on dapagliflozin (Forxiga) for chronic kidney disease in adults.
Evidence-based recommendations on transurethral electrovaporisation of the prostate (TURP) to treat benign prostatic obstruction (BPO). This involves using a high-voltage electrical current to vaporise some of the prostate.
NICE has developed a medtech innovation briefing (MIB) on LQD Spray for treating acute and chronic wounds .
applicable) Why this is important:- The evidence review for the NICE guideline on hearing loss found a lack of evidence to establish the...
Lenus COPD Support Service for remotely managing chronic obstructive pulmonary disease (MIB300)
NICE has developed a medtech innovation briefing (MIB) on Lenus COPD Support Service for remotely managing chronic obstructive pulmonary disease .
Xpert GBS test for the intrapartum detection of group B streptococcus (MIB28)
NICE has developed a medtech innovation briefing (MIB) on Xpert GBS test for the intrapartum detection of group B streptococcus
Empagliflozin in combination therapy for treating type 2 diabetes (TA336)
Evidence-based recommendations on empagliflozin (Jardiance) in combination therapy for treating type 2 diabetes.
Evidence-based recommendations on laparoscopic laser myomectomy. This involves passing a fine telescope (laparascope) through small cuts in the abdomen and uterus wall, and using a laser to destroy the fibroids.
View recommendations for IPG23Show all sections
O2matic PRO 100 for optimising oxygen treatment in respiratory conditions (MIB308)
NICE has developed a medtech innovation briefing (MIB) on O2matic PRO 100 for optimising oxygen treatment in respiratory conditions .
Evidence-based recommendations on CYP2C19 genotype testing to guide clopidogrel use after ischaemic stroke or transient ischaemic attack
Tucatinib with trastuzumab for previously treated HER2-positive colorectal cancer [ID6227]
In development [GID-TA11228] Expected publication date: TBC